Home › Niet-kleincellige longkanker › Illinois › Waukegan
Niet-kleincellige longkanker klinische studies in Waukegan, IL
16 studies voor Niet-kleincellige longkanker zoeken deelnemers op locaties in en rond Waukegan (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RekruterenFase 3
- AMG Libertyville - Oncology, Libertyville · 8 mijl verwijderd
- Condell Memorial Hospital, Libertyville · 8 mijl verwijderd
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RekruterenFase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mijl verwijderd
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mijl verwijderd
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
RekruterenFase 2
- City of Hope Chicago, Zion · 6 mijl verwijderd
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
RekruterenFase 3
- Advocate Medical Group - Libertyville Oncology, Libertyville · 8 mijl verwijderd
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
RekruterenFase 3
- Captain James A. Lovell Federal Health Care Center, North Chicago · 3 mijl verwijderd
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RekruterenFase 3
- City of Hope® Cancer Center Chicago, Zion · 6 mijl verwijderd
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
RekruterenFase 3
- Research Site, Zion · 6 mijl verwijderd
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
RekruterenFase 3
- Research Site, North Chicago · 3 mijl verwijderd
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
RekruterenFase 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mijl verwijderd
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mijl verwijderd
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
RekruterenFase 3
- Cancer Treatment Centers of America (CTCA), Zion · 6 mijl verwijderd
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RekruterenFase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mijl verwijderd
- AMG Libertyville - Oncology, Libertyville · 8 mijl verwijderd
- Condell Memorial Hospital, Libertyville · 8 mijl verwijderd
- en nog 1
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mijl verwijderd
- AMG Libertyville - Oncology, Libertyville · 8 mijl verwijderd
- Condell Memorial Hospital, Libertyville · 8 mijl verwijderd
- en nog 1
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2/3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mijl verwijderd
- AMG Libertyville - Oncology, Libertyville · 8 mijl verwijderd
- Condell Memorial Hospital, Libertyville · 8 mijl verwijderd
- en nog 1
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RekruterenFase 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mijl verwijderd
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mijl verwijderd
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
RekruterenFase 2
- City of Hope at Chicago, Zion · 6 mijl verwijderd
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekruterenObservatieonderzoek
- AMG Libertyville - Oncology, Libertyville · 8 mijl verwijderd
- Condell Memorial Hospital, Libertyville · 8 mijl verwijderd
Niet-kleincellige longkanker studies in andere steden
- Houston, TX145 studies
- New York City, NY121 studies
- Arlington, VA104 studies
- Nashville, TN97 studies
- Boston, MA90 studies
- Los Angeles, CA87 studies
- St. Louis, MO73 studies
- Chicago, IL61 studies
- Baltimore, MD60 studies
- San Antonio, TX59 studies
- Columbus, OH57 studies
- Washington, DC55 studies
Andere studies in Waukegan
- Longkanker16 studies
- Borstkanker12 studies
- Colitis ulcerosa7 studies
- Nierkanker (niercelcarcinoom)7 studies
- Eierstokkanker6 studies
- Metastatische kanker6 studies
- Plaveiselcelcarcinoom van hoofd en hals6 studies
- Colorectale kanker6 studies
- Prostaatkanker6 studies
- Melanoom5 studies
- Acute myeloïde leukemie5 studies
- Ziekte van Crohn5 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.